ARCHIVES

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

This article is from The Cancer Letter archive.

Vol. 25 No. 13 | April 2, 1999

Download PDF Visit The Full Archive

Related Articles

Senate Defeats Attempt To Cut NIH Funds

July 8, 1977

Grants Awarded To Combat Tobacco In Developing Countries

October 4, 2002

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

January 25, 2002

Final Issue Of 1992

December 11, 1992

ACS Picks Up Study Of tobacco Industry Influence On Voting By State Legislators

May 3, 1996

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

April 27, 2012